Portfolio Companies News
March 23, 2017HealthCap's 39th IPO as HealthCap V...
MIPS AB has successfully completed its Initial Public Offering on Nasdaq OMX Stockholm’s main market. Trading started today under the ticker MIPS. Source: MIPS
March 23, 2017Targovax ASA moves share listing to...
Published: 07:00 CET 23-03-2017 /GlobeNewswire /Source: Targovax ASA / : TRVX /ISIN: NO0010689326 Targovax ASA moves share listing to Oslo Børs Oslo, Norway, 23 March 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-... read more
March 22, 2017BioClin Therapeutics, Inc., Raises ...
BioClin Therapeutics, Inc., a privately-held clinical stage drug development company developing a first-in-class anti-FGFR3 (fibroblast growth factor receptor 3) monoclonal antibody in areas of high unmet medical need, announced today the closing of a $30 million Series B financing. The financing wa... read more
March 22, 2017Nexstim Plc Signs an Independent Se...
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new Independent Selling Representative Agreement in the U.S. with JTec Sur... read more
March 22, 2017Aprea Therapeutics Announces Resear...
March 22, 2017—BOSTON, MA., and STOCKHOLM, SWEDEN, March 22, 2017 – Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, today announced a collaboration with Memorial Sloan Kettering Cance... read more
February 06, 2017Q4 2016 General Market Overview